Location of Repository

Haemostasis, inflammation and renal function following exercise in patients with intermittent claudication on statin and aspirin therapy

By Patrick Collins, Isobel Ford, Bernard Croal, Derek Ball, Michael Greaves, Ewan Macaulay and Julie Brittenden
Topics: Original Clinical Investigation
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:1540420
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (1993). A: C-reactive protein and alpha-1-acid glycoprotein in monitoring of patients with chronic arterial occlusion of the lower limbs.
    2. (1987). A: Early detection of the nephrotoxic effects of industrial chemicals: state of the art and future prospects. [Review] [41 refs].
    3. (1990). Assessment of hypercoagulable states by measurement of activation fragments and peptides. Blood Rev
    4. (1990). Assessment of renal function: selected developments. Clin Biochem
    5. (1999). Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis
    6. (2003). AW: Exercise in claudicants is accompanied by excessive thrombin generation.
    7. (2004). AW: Exercise training enhances endogenous fibrinolysis in peripheral arterial disease. J Vasc Surg
    8. (2002). AW: What constitutes best medical therapy for peripheral arterial disease?. [Review] [71 refs].
    9. (2003). BR: Effect of statins on C-reactive protein and interleukin-6 (the Ludwigshafen risk and cardiovascular health study). AJC
    10. (1994). CN: Systemic responses in patients with intermittent claudication after treadmill exercise. BJS
    11. (1998). Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Scie Sports Exe
    12. (1997). CP: Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response?
    13. (1998). CP: The evidence for exercise-induced inflammation in intermittent claudication: should we encourage patients to stop walking?
    14. (1994). DL: Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease.
    15. (2004). E: Exercise for intermittent claudication. Cochrane Peripheral Vascular Diseases Group Cochrane Database of Systematic Reviews.
    16. (2002). Exercise training reduces the acute inflammatory response associated with claudication.
    17. (1998). Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation
    18. (2004). Inflammation, immunity, and HMG-CoA reductase inhibitors statins as antiinflammatory agents? [Review] [133 refs]. Circulation
    19. (2005). KG: Statins and blood coagulation.
    20. (1994). Kidney function during exercise in healthy and diseased humans. An update. [Review] [92 refs]. Sports Medicine
    21. (1988). Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma. Clin Chem
    22. (2005). Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
    23. (1994). McCollum CN: Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis.
    24. (1992). MH: Claudication induces systemic capillary endothelial swelling.
    25. (1988). MH: Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease?
    26. (2003). Patients with critical ischemia of the lower limb are at risk of developing kidney dysfunction.
    27. (1998). Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.
    28. (2001). PM: The systemic effects of intermittent claudication are reversed by angioplasty.
    29. (1994). PW: Fibrin formation and degradation in patients with arteriosclerotic disease. Circulation
    30. (1990). Simms MH: Assessment of intermittent claudication by quantitation of exerciseinduced microalbuminuria.
    31. (1993). Simms MH: Intermittent claudication incites systemic neutrophil activation and increased vascular permeability. BJS
    32. (1992). The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. [Review] [40 refs]. Clinical Nephrology
    33. (1983). Use of single voided urine samples to estimate quantitative proteinuria. NEJM
    34. (2003). V: High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med
    35. (1996). Wenham PW: Randomized controlled trial of the effect of mannitol on renal reperfusion injury during aortic aneurysm surgery. BJS

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.